Groundbreaking UK “mega-trial” will test existing drugs as new treatments for MS
In a world-first “mega-trial”, UK experts will test a range of drugs already approved for other illnesses for the treatment…
Simplifying Clinical Trials
In association with Teckro
Arch Biopartners secures approval to amend LSALT Peptide trial protocols
Canadian firm Arch Biopartners has secured approval to make certain protocol amendments to the Phase II trial of its lead…
Latest News
View More
How digital transformation can bring clinical trials into the 21st century
In the digital era, we have gotten used to searching and retrieving almost any information we require within seconds. Because people asked “what if?”, we…
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Drug development is extremely challenging no matter the condition – nine in ten drugs fail in clinical trials. However, this worrying situation is even more…